Clark AJ - Search Results

1

Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity.

Metherell LA, Akker SA, Munroe PB, Rose SJ, Caulfield M, Savage MO, Chew SL, Clark AJ. Metherell LA, et al. Among authors: clark aj. Am J Hum Genet. 2001 Sep;69(3):641-6. doi: 10.1086/323266. Epub 2001 Jul 20. Am J Hum Genet. 2001. PMID: 11468686 Free PMC article.

2

Diagnostic and therapeutic advances in growth hormone insensitivity.

David A, Metherell LA, Clark AJ, Camacho-Hübner C, Savage MO. David A, et al. Among authors: clark aj. Endocrinol Metab Clin North Am. 2005 Sep;34(3):581-95, viii. doi: 10.1016/j.ecl.2005.04.009. Endocrinol Metab Clin North Am. 2005. PMID: 16085161 Review.

3

Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders.

Savage MO, Attie KM, David A, Metherell LA, Clark AJ, Camacho-Hübner C. Savage MO, et al. Among authors: clark aj. Nat Clin Pract Endocrinol Metab. 2006 Jul;2(7):395-407. doi: 10.1038/ncpendmet0195. Nat Clin Pract Endocrinol Metab. 2006. PMID: 16932322 Review.

4

An intronic growth hormone receptor mutation causing activation of a pseudoexon is associated with a broad spectrum of growth hormone insensitivity phenotypes.

David A, Camacho-Hübner C, Bhangoo A, Rose SJ, Miraki-Moud F, Akker SA, Butler GE, Ten S, Clayton PE, Clark AJ, Savage MO, Metherell LA. David A, et al. Among authors: clark aj. J Clin Endocrinol Metab. 2007 Feb;92(2):655-9. doi: 10.1210/jc.2006-1527. Epub 2006 Dec 5. J Clin Endocrinol Metab. 2007. PMID: 17148568

5

A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein.

Woods KA, Fraser NC, Postel-Vinay MC, Savage MO, Clark AJ. Woods KA, et al. Among authors: clark aj. J Clin Endocrinol Metab. 1996 May;81(5):1686-90. doi: 10.1210/jcem.81.5.8626815. J Clin Endocrinol Metab. 1996. PMID: 8626815

6

[Phenotype-genotype relations in growth hormone insensitivity].

Savage MO, Woods KA, Clark AJ, Amselem S. Savage MO, et al. Among authors: clark aj. Arch Pediatr. 1998;5 Suppl 4:364S-370S. doi: 10.1016/s0929-693x(99)80192-4. Arch Pediatr. 1998. PMID: 9853085 French.

7

Relationship between phenotype and genotype in growth hormone insensitivity syndrome.

Woods KA, Clark AJ, Amselem S, Savage MO. Woods KA, et al. Among authors: clark aj. Acta Paediatr Suppl. 1999 Feb;88(428):158-62; discussion 163. doi: 10.1111/j.1651-2227.1999.tb14376.x. Acta Paediatr Suppl. 1999. PMID: 10102073 Review.

8

Repair of aberrant splicing in growth hormone receptor by antisense oligonucleotides targeting the splice sites of a pseudoexon.

David A, Srirangalingam U, Metherell LA, Khoo B, Clark AJ. David A, et al. Among authors: clark aj. J Clin Endocrinol Metab. 2010 Jul;95(7):3542-6. doi: 10.1210/jc.2009-1968. Epub 2010 Apr 28. J Clin Endocrinol Metab. 2010. PMID: 20427506 Free article.

9

Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity.

David A, Hwa V, Metherell LA, Netchine I, Camacho-Hübner C, Clark AJ, Rosenfeld RG, Savage MO. David A, et al. Among authors: clark aj. Endocr Rev. 2011 Aug;32(4):472-97. doi: 10.1210/er.2010-0023. Epub 2011 Apr 27. Endocr Rev. 2011. PMID: 21525302 Review.

10

Spontaneous growth hormone secretory characteristics in children with partial growth hormone insensitivity.

Bjarnason R, Banerjee K, Rose SJ, Rosberg S, Metherell L, Clark AJ, Albertsson-Wikland K, Savage MO. Bjarnason R, et al. Among authors: clark aj. Clin Endocrinol (Oxf). 2002 Sep;57(3):357-61. doi: 10.1046/j.1365-2265.2002.01607.x. Clin Endocrinol (Oxf). 2002. PMID: 12201828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

903 results

Search Page